search
Back to results

Early Exclusive Enteral Nutrition in Early Preterm Infants

Primary Purpose

Enteral Nutrition

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Early exclusive enteral nutrition
Sponsored by
Belal Alshaikh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Enteral Nutrition focused on measuring Exclusive, Enteral Nutrition, Preterm Infant

Eligibility Criteria

undefined - 48 Hours (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Preterm infants born at 30 0/7 - 33 6/7 weeks gestation
  2. Birth weight greater than 1000 g
  3. Consent to use donor human milk
  4. Postnatal age is less than 48 hours from birth
  5. Infant is ready to start on feeding (as per clinical team) or feeding volume, when already started, is ≤12 ml/kg per day (total) and/or the infant received ≤2 feeds based on current feeding policy or physician descrition (total volume of the received feeds is ≤20 ml/kg per day).

Exclusion Criteria:

  1. Cord PH < 7.00 or Cord base access (BE) < -16
  2. Apgar score < 7 at 5 minute
  3. Lactate level ≥3 (if done for clinical indication)
  4. Need for positive pressure ventilation (PPV) for >1 minute.
  5. Hemodynamic instability (hypotension or poor perfusion at any time in this 48 hours)
  6. Small for gestational age <3 percentile on Fenton chart and/or fetal absent or reversed umbilical arterial end-diastolic blood flow.
  7. Major congenital malformation
  8. Symptomatic or severe hypoglycemia (blood glucose <1.8 mmol/L)
  9. Infants with moderate to severe respiratory distress.

Sites / Locations

  • Peter Lougheed HospitalRecruiting
  • Foothills Medical CentreRecruiting
  • South Health CampusRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Early Exclusive Enteral Nutrition

Conventional Enteral Nutrition

Arm Description

Feeds will start at least at 80% of reference daily fluid intake from day one of life. Feeds will be advanced by 20-30 ml/kg per day on second day onwards until infant reaches full enteral feed.

Infants will be fed as per current Neonatal Intensive Care Unit feeding tables: Infants with birth weight 1000-1500 g will be fed on 15-20 ml/kg human milk in day one. Feeds will be advanced by 15-20 ml/kg per day on second day onwards until infant reaches full enteral feeds. Infants with birth weight >1500 g will be started on 20-30 ml/kg per day on day one. Feeds will be advanced by 20-30 ml/kg per day on second day onwards until infant reaches full enteral feeds.

Outcomes

Primary Outcome Measures

Duration to achieve of full enteral feeds in days
Day of life to achieve full enteral feeding defined as 140 ml/kg/day which is sustained for at least 3 days

Secondary Outcome Measures

Length of hospital stay
Length of hospital stay in days
Feeding intolerance
Presence of one or more of the following: vomiting more than 2 times during any 24 h period, any episode of bile- or blood-stained vomiting, abdominal wall erythema or tenderness that resulted in cessation of feed.
Incidence of late onset sepsis
Any microbial growth in blood, cerebrospinal fluid or urine after 72 hours of admission in NICU
Incidence of NEC
Any Stage II and above according to Bell's staging criteria
Incidence of hypoglycemia
Defined as point of care testing Glucose < 2.6 mmol/L at any time after rollment in study

Full Information

First Posted
October 1, 2018
Last Updated
December 19, 2021
Sponsor
Belal Alshaikh
search

1. Study Identification

Unique Protocol Identification Number
NCT03708068
Brief Title
Early Exclusive Enteral Nutrition in Early Preterm Infants
Official Title
Early Exclusive Enteral Nutrition in Stable Preterm Infants at 30 0/7 - 33 6/7 Weeks Gestation: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Unknown status
Study Start Date
April 16, 2019 (Actual)
Primary Completion Date
November 2022 (Anticipated)
Study Completion Date
November 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Belal Alshaikh

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Enteral nutrition in preterm infants is usually started and advanced slowly until reaching full enteral feeds. Most preterm infants born before 34 weeks gestation require parenteral fluids to maintain normal blood sugar level and prevent excessive weight loss and dehydration. Availability of donor human milk (DHM) along with low incidence of necrotizing enterocolitis (NEC) in preterm infants born at 30-33 weeks have encouraged neonatologists to start feeding early and advance it faster in order to shorten time on parenteral nutrition (PN) and minimize the need for intravenous access. The objectives of this trial is to study whether exclusive enteral nutrition from day of birth (i.e. no PN) results in shorter time to achieve full enteral feed when compared with traditional feeding regimen that involves a combination of PN and progressive enteral feeding.
Detailed Description
Early nutritional support of preterm infants born at 30-33 weeks gestation is usually achieved via a combination of parenteral nutrition (PN) and enteral feeding that is advanced over few days to reach full enteral feed. Recent studies suggest that rapid increase of enteral feed volumes results in shorter duration on PN and earlier achievement of full enteral feed without increasing the risk of necrotizing enterocolitis (NEC) or death. Although PN has an important role in nutrition of preterm infants, it is associated with increased risk of metabolic and infectious complications even when it is used for a short period of time. Furthermore, PN mandates the need for peripheral or central intravenous access. Provision of full enteral feed volume that meets reference daily fluid intake from day of birth is used frequently and successfully in stable preterm infants born after 33 weeks. Expanding the use of this regimen to stable preterm infants born at 30-33 weeks gestation may help avoid unnecessary start of intravenous access, prevent complications related to PN, and encourage mother-infant bonding experience.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Enteral Nutrition
Keywords
Exclusive, Enteral Nutrition, Preterm Infant

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
68 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Early Exclusive Enteral Nutrition
Arm Type
Experimental
Arm Description
Feeds will start at least at 80% of reference daily fluid intake from day one of life. Feeds will be advanced by 20-30 ml/kg per day on second day onwards until infant reaches full enteral feed.
Arm Title
Conventional Enteral Nutrition
Arm Type
No Intervention
Arm Description
Infants will be fed as per current Neonatal Intensive Care Unit feeding tables: Infants with birth weight 1000-1500 g will be fed on 15-20 ml/kg human milk in day one. Feeds will be advanced by 15-20 ml/kg per day on second day onwards until infant reaches full enteral feeds. Infants with birth weight >1500 g will be started on 20-30 ml/kg per day on day one. Feeds will be advanced by 20-30 ml/kg per day on second day onwards until infant reaches full enteral feeds.
Intervention Type
Other
Intervention Name(s)
Early exclusive enteral nutrition
Other Intervention Name(s)
Early Total Enteral Feed
Intervention Description
Infants will be fed at least 80% of reference daily fluid intake from day one. Feeds will be advanced by 20-30 ml/kg per day on second day onwards to meet reference daily fluid intake until infant reaches full enteral feed.
Primary Outcome Measure Information:
Title
Duration to achieve of full enteral feeds in days
Description
Day of life to achieve full enteral feeding defined as 140 ml/kg/day which is sustained for at least 3 days
Time Frame
Till 30 days of life
Secondary Outcome Measure Information:
Title
Length of hospital stay
Description
Length of hospital stay in days
Time Frame
At discharge from neonatal intensive care unit (NICU), up to 90 days of life
Title
Feeding intolerance
Description
Presence of one or more of the following: vomiting more than 2 times during any 24 h period, any episode of bile- or blood-stained vomiting, abdominal wall erythema or tenderness that resulted in cessation of feed.
Time Frame
Till 30 days of life
Title
Incidence of late onset sepsis
Description
Any microbial growth in blood, cerebrospinal fluid or urine after 72 hours of admission in NICU
Time Frame
At discharge from NICU, up to 90 days of life
Title
Incidence of NEC
Description
Any Stage II and above according to Bell's staging criteria
Time Frame
At discharge from NICU, up to 90 days of life
Title
Incidence of hypoglycemia
Description
Defined as point of care testing Glucose < 2.6 mmol/L at any time after rollment in study
Time Frame
Till 30 days of life

10. Eligibility

Sex
All
Maximum Age & Unit of Time
48 Hours
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Preterm infants born at 30 0/7 - 33 6/7 weeks gestation Birth weight greater than 1000 g Consent to use donor human milk Postnatal age is less than 48 hours from birth Infant is ready to start on feeding (as per clinical team) or feeding volume, when already started, is ≤12 ml/kg per day (total) and/or the infant received ≤2 feeds based on current feeding policy or physician descrition (total volume of the received feeds is ≤20 ml/kg per day). Exclusion Criteria: Cord PH < 7.00 or Cord base access (BE) < -16 Apgar score < 7 at 5 minute Lactate level ≥3 (if done for clinical indication) Need for positive pressure ventilation (PPV) for >1 minute. Hemodynamic instability (hypotension or poor perfusion at any time in this 48 hours) Small for gestational age <3 percentile on Fenton chart and/or fetal absent or reversed umbilical arterial end-diastolic blood flow. Major congenital malformation Symptomatic or severe hypoglycemia (blood glucose <1.8 mmol/L) Infants with moderate to severe respiratory distress.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Belal Alshaikh, MD
Phone
403-956-1588
Email
balshaik@ucalgary.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Belal Alshaikh, MD
Organizational Affiliation
University of Calgary
Official's Role
Principal Investigator
Facility Information:
Facility Name
Peter Lougheed Hospital
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T1Y6J4
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Belal Alshaikh, MD
First Name & Middle Initial & Last Name & Degree
Essa Al Awad, MD
First Name & Middle Initial & Last Name & Degree
Nalini Singhal, MD
Facility Name
Foothills Medical Centre
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2N2T9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Belal Alshaikh, MD
First Name & Middle Initial & Last Name & Degree
Belal Alshaikh, MD
First Name & Middle Initial & Last Name & Degree
Dinesh Dharel, MD
Facility Name
South Health Campus
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T3M1P9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Belal Alshaikh, MD
First Name & Middle Initial & Last Name & Degree
Belal Alshaikh, MD
First Name & Middle Initial & Last Name & Degree
Ruma Jain, MD

12. IPD Sharing Statement

Learn more about this trial

Early Exclusive Enteral Nutrition in Early Preterm Infants

We'll reach out to this number within 24 hrs